← Back to Clinical Trials
Recruiting NCT07138768

Role of MRI in the Early Diagnosis and Management of Acute Stroke and Its Impact on Turnaround Time in Emergency Settings

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Magnetic Resonance Imaging
Sponsor Tanta University
Study Type OBSERVATIONAL
Phase N/A
Enrollment 136
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2025-08-23
Completion 2026-12-01
Interventions
Magnetic Resonance Imaging

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This study aims to evaluate the role of stroke protocol in the early diagnosis and management of acute stroke and its effect on turnaround time (TAT) in emergency settings.

Eligibility Criteria

Inclusion Criteria: * Age ≥18 years. * Both sexes. * Patients with acute stroke who are admitted to the emergency department. Exclusion Criteria: * Contraindications to magnetic resonance imaging (MRI) or computed tomography (CT). * Symptoms strongly suggestive of subarachnoid hemorrhage. * Initiation of antithrombotic or thrombolytic treatment before the completion of both scans. * Inability to complete both scans in time to allow thrombolytic treatment within three h of the onset of symptoms. * Uncontrollable hypertension. * Pregnant or lactating women.

Related Trials

VIEW ON CLINICALTRIALS.GOV ↗ MORE MAGNETIC RESONANCE IMAGING TRIALS
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}